Epithelial-mesenchymal Transition Factor and Its Association With Mammographic Density and Breast Cancer Prognosis

被引:1
作者
Kim, Eun Young [1 ]
Ahn, Sangjeong [2 ,3 ]
机构
[1] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Surg, Sch Med, Seoul, South Korea
[2] Korea Univ, Anam Hosp, Coll Med, Dept Pathol, Seoul, South Korea
[3] Korea Univ, Anam Hosp, Coll Med, Dept Pathol, 73 Goryeodae ro, Seoul 02841, South Korea
关键词
Breast carcinoma; epithelial mesenchymal transition; mammographic breast density; prognosis; CELLS; EXPRESSION; CD34; PROGRESSION; VIMENTIN; INVASION; RISK;
D O I
10.21873/anticanres.16392
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background/Aim: The tumor microenvironment influences tumor progression, invasion, and metastasis. This study determined the expression levels of epithelialmesenchymal transition (EMT) factors according to zone and their correlation with mammographic breast density and investigated the prognostic value of EMT factors. Patients and Methods: The clinical and pathological data of invasive carcinoma and ductal carcinoma in situ were reviewed. Primary breast tissue samples were evaluated using immunohistochemistry (IHC) staining of the EMTassociated markers, including alpha-SMA, vimentin, MMP-9, and CD34. The expression levels were analyzed in three areas: the tumor center, interface, and distal zones. EMT factors were correlated with mammographic breast density and oncologic outcomes. Results: An overall EMT phenotype conversion from positive to negative was seen in 55.7% of alpha-SMA- and 34.4% of MMP-9-positive cells between the tumor center and interface zones, which was significantly different (p<0.05). Most changes in EMT expression from the center to the distal zone were from positive to negative, but 23.0% of CD34-expressing cells showed negative to positive conversion. The proportion of alpha-SMA, vimentin, and MMP-9 expression was higher in the non-dense breast group compared to the dense breast group in the interface and distal zones (p<0.05). CD34 expression in the distal zone was an independent favorable prognostic factor for disease-free survival (p=0.039). Conclusion: The differential expression of EMT markers in each zone suggests heterogeneous cancer cell populations within each zone of breast cancer. EMT factor expression can also interplay between breast density stroma and geographical tumor zone.
引用
收藏
页码:2281 / 2292
页数:12
相关论文
共 50 条
  • [41] Overexpression of SPARC correlates with poor prognosis in patients with cervical carcinoma and regulates cancer cell epithelial-mesenchymal transition
    Shi, Dehuan
    Jiang, Kan
    Fu, Ying
    Fang, Rui
    Liu, Xi
    Chen, Jie
    ONCOLOGY LETTERS, 2016, 11 (05) : 3251 - 3258
  • [42] Epithelial-mesenchymal transition status of circulating tumor cells in breast cancer and its clinical relevance
    Zhou, Jiaojiao
    Zhu, Xuan
    Wu, Shijie
    Guo, Jingxin
    Zhang, Kun
    Xu, Chunjing
    Chen, Huihui
    Jin, Yuxi
    Sun, Yuting
    Zheng, Shu
    Chen, Yiding
    CANCER BIOLOGY & MEDICINE, 2020, 17 (01) : 169 - +
  • [43] Epithelial-mesenchymal Transition and Cancer Stem Cells in Endometrial Cancer
    Supernat, Anna
    Lapinska-Szumczyk, Sylwia
    Majewska, Hanna
    Gulczynski, Jacek
    Biernat, Wojciech
    Wydra, Dariusz
    Zaczek, Anna J.
    ANTICANCER RESEARCH, 2013, 33 (12) : 5461 - 5469
  • [44] Association of epithelial-mesenchymal transition and nuclear cofilin with advanced urothelial cancer
    Hensley, Patrick J.
    Zetter, Daniel
    Horbinski, Craig M.
    Strup, Stephen E.
    Kyprianou, Natasha
    HUMAN PATHOLOGY, 2016, 57 : 68 - 77
  • [45] Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma
    Tao, Chuming
    Huang, Kai
    Shi, Jin
    Hu, Qing
    Li, Kuangxun
    Zhu, Xingen
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [46] Clinical significance and immune characteristics analysis of miR-221-3p and its key target genes related to epithelial-mesenchymal transition in breast cancer
    Fang, Yutong
    Zhang, Qunchen
    Chen, Zexiao
    Guo, Cuiping
    Wu, Jundong
    AGING-US, 2024, 16 (01): : 322 - 347
  • [47] Inhibition of notch signaling reverses epithelial-mesenchymal transition in esophageal cancer
    Zhou, Xue-Liang
    Xu, Qi-Rong
    Fang, Yi-Hu
    Xu, Hua
    Zou, Bin
    Xue, Chun-Zhu
    Liu, Ji-Chun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (04): : 6421 - 6428
  • [48] Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis
    Sung, Woo Jung
    Park, Ki-Sung
    Kwak, Sang Gyu
    Hyun, Dae-Sung
    Jang, Jae Seok
    Park, Kwan-Kyu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (08): : 8997 - 9009
  • [49] Subcellular proteomics revealed the epithelial-mesenchymal transition phenotype in lung cancer
    Li, Li-Ping
    Lu, Chun-Hua
    Chen, Zhi-Peng
    Ge, Feng
    Wang, Tong
    Wang, Wei
    Xiao, Chuan-Le
    Yin, Xin-Feng
    Liu, Langxia
    He, Jian-Xing
    He, Qing-Yu
    PROTEOMICS, 2011, 11 (03) : 429 - 439
  • [50] Role of MMP-9 in epithelial-mesenchymal transition of thyroid cancer
    Li, Yuanchun
    He, Jing
    Wang, Feng
    Wang, Xin
    Yang, Fan
    Zhao, Chunyang
    Feng, Chunling
    Li, Tiejun
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2020, 18 (01)